Revelation Biosciences, Inc. logo

REVBRevelation Biosciences, Inc.

REVB Stock Price, Valuation & Chart | Revelation Biosciences, Inc.

Compare

REVB Historical price chart

REVB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization3.91M
PE Ratio-0.05
EPS-18.45
Trading Volume18.00K
Today's High/Low1.04/0.99
Dividend Yield0.00
52 Week High/Low11.6/0.88
Shares Outstanding3.91M
REVB Financial Statement
REVB Analyst ratings
REVB Analysis & performance metrics

REVB Company profile

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The…

REVB Management team

Management
Chester Stanley Zygmont IIICFO
Chief Financial Officer & Corporate Secretary
Carol OdleCTO
Senior Director of Clinical Projects
Sandra Vedrick
Vice President of Human Resources & Investor Relations
James M. RolkeCEO
Chief Executive Officer & Director
Total 4 executives

REVB Frequently asked questions

What is Revelation Biosciences, Inc. (REVB) Stock Price?

Current stock price of Revelation Biosciences, Inc. (REVB) stock is $1.000. The stock price is +1.36% higher in the session. The intraday range can be seen from this page. Volume of Revelation Biosciences, Inc. (REVB) stock is 18.00K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Revelation Biosciences, Inc. (REVB) stock price going up or down today?

The stock price of Revelation Biosciences, Inc. (REVB) can change with earnings, company news, and overall market sentiment. Revelation Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Revelation Biosciences, Inc. stock expensive at its current price?

Whether Revelation Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for REVB on this page is -0.05. EPS on this page is -18.45. Compare those figures with peers and growth expectations before deciding if the current Revelation Biosciences, Inc. price is justified.

How has the stock price of Revelation Biosciences, Inc. (REVB) performed historically?

Historical performance for Revelation Biosciences, Inc. (REVB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how REVB reacted to past earnings and market events.

Should I buy Revelation Biosciences, Inc. (REVB) stock, at this price?

Buying Revelation Biosciences, Inc. (REVB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.